(Q43011355)

12 November 2017

Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases (English)

1 reference

12 November 2017

0 references

Huang L

1

1 reference

12 November 2017

Cheng YY

2

1 reference

12 November 2017

Chow LT

3

1 reference

12 November 2017

Zheng MH

4

1 reference

12 November 2017

Kumta SM

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of Clinical Pathology

12 November 2017

1 reference

12 November 2017

55

1 reference

12 November 2017

11

1 reference

12 November 2017

877-878

1 reference

Biology of osteoclast activation in cancer

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Osteoprotegerin and rank ligand expression in prostate cancer

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Molecular mechanisms of tumor-bone interactions in osteolytic metastases

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769799

Breast cancer cells interact with osteoblasts to support osteoclast formation

26 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12401833

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.55.11.877

1 reference

release_2dew5hsp75hplfjinsul3xjhoy

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2dew5hsp75hplfjinsul3xjhoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 November 2017

PubMed publication ID

12401833

1 reference